Phrenic Nerve Infiltration in Fibromyalgia

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

February 19, 2024

Study Completion Date

February 19, 2024

Conditions
Fibromyalgia
Interventions
DRUG

Bupivacain

The experimental intervention will consist of ultrasound-guided anesthetic blockade of the phrenic nerve at the laterocervical supraclavicular level with 1 ml of lidocaine without vasoconstrictor 2% to infiltrate the skin and 3ml of bupivacaine without vasoconstrictor 0.25% for neural blockade, making the local anesthetic surround the nerve between the anterior scalene muscle and the sternocleidomastoid muscle.

OTHER

Placebo (physiological saline serum infiltration)

The placebo intervention will be similar in relation to 2% lidocaine without vasoconstrictor for the skin, but an ultrasound-guided puncture will be performed at the level of the subcutaneous cellular tissue by injecting 3 ml of physiological saline.

Trial Locations (4)

41009

Hospitales Universitarios Virgen del Rocío y Macarena, Seville

41018

Asociación de Fibromialgia de Sevilla, Seville

41089

Nacho Navarro Fisioterapia, Dos Hermanas

41740

Asociación de Fibromialgia de Lebrija, Lebrija

All Listed Sponsors
lead

University of Seville

OTHER